Vista Center Health Library

The Health Library at Vista Center is dedicated to providing accessible health information and resources to help people with vision loss understand their conditions and keep abreast of new treatments and research findings. We also provide custom information about health and vision loss in an accessible format.

Sign Up For Health Library Email List

We don’t spam. Our Privacy Policy and Terms of Service apply. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Resource Category
Medical Condition


A group of eye diseases that can cause vision loss and blindness by damaging a nerve in the back of your eye called the optic nerve. 

Clinical trials

Clinical studies look at the safety of the drug.

Avacincaptad pegol shows promising vision loss reduction rate in geographic atrophy

A post hoc analysis of data from the phase 3 GATHER1 and GATHER2 clinical trials showed that avacincaptad pegol (ACP), an investigational complement C5 inhibitor,  achieved positive results in vision loss reduction in patients with geographic atrophy (GA)

EyePoint, Rallybio collaboration to focus on sustained delivery of C5 inhibitor in geographic atrophy

EyePoint Pharmaceuticals and Rallybio have entered a research collaboration to investigate sustained delivery of Rallybio’s complement C5 inhibitor using EyePoint’s Durasert technology.

Vision improvements sustained with photobiomodulation at 24 months in dry AMD trial

Photobiomodulation (PBM) delivered with the Valeda light delivery system demonstrated sustained improvements in best corrected visual acuity at 24 months in patients with dry AMD, according to a press release from LumiThera.

Commonly used self-test for AMD found to be inaccurate

In a recent meta-analysis study published in JAMA Ophthalmology, researchers evaluated how well the test actually detected wet AMD.

Retinal flavoprotein fluorescence could be new biomarker of AMD stage, progression

Until recently, mitochondria were not visible and couldn’t be counted in live tissue but advances in retinal imaging have now made this possible.

Discovery suggests new way to prevent common causes of vision loss

In new research, UVA Health scientists have discovered a new target to prevent the formation of abnormal tangles of blood vessels.

Combining multiple maps reveals new genetic risk factors for blindness

Combining a map of gene regulatory sites (which control how much functional product, such as a protein, a gene produces) with disease-associated loci (position on a chromosome where a gene is located) has uncovered a new genetic risk factor of AMD.

Gene therapy shows potential for RPE65-related retinal dystrophy

Children with a rare, inherited retinal disorder who were treated with the first Food and Drug Administration-approved gene therapy had noticeable improvements in vision that may be related to recovery of photoreceptor health.

Disclaimer: Reports are excerpted/edited unless otherwise noted. Medical definitions are provided via Google/medical dictionaries. This project is done as a courtesy to the blind and visually impaired community. We do not recommend any particular treatment. Our Material might not represent all that is available on the subject. This information might not apply specifically to your own condition. Our material is not intended as a substitute for medical care. Our material should be used to formulate questions for discussion with your physician. We hope that the information you find at The Health Library will be useful in communicating with your health professionals. If you have any questions about your unique medical condition, we strongly advise that you see your physician.

The Health Library at Vista Center is maintained by Miriam Kaplan, PhD, Editor-in-Chief and Coordinator, and Dawn Wilcox BSN RN, Associate Editor.  The Health Library at Vista Center is an affiliate of the Stanford Hospital Health Library.